Although the exact mechanism remains unclear, accumulating evidence highlights the regulatory roles of the estrogen and/or androgen receptors signaling in the key chromatin-modifying enzymes and metabolic microRNAs in the pathogenesis of both type 2 diabetes and HCC (25). Here, AR is linked to hepatocellular carcinoma.